樂遊科技控股(01089.HK):控股股東鬱國祥洽售股份延長獨家期
格隆匯3月12日丨樂遊科技控股(01089.HK)會宣佈,於2020年3月12日,鬱國祥及公司與潛在買方訂立獨家協議,內容有關潛在買方將就公司的全部已發行股份作出可能附先決條件自願有條件要約。
根據獨家協議,潛在買方已獲授予於獨家協議日期開始及於2020年4月15日(或根據獨家協議延長之有關較後日期或訂約方可能書面協定之有關其他日期);或(ii)潛在買方書面通知鬱國祥及公司潛在買方不再有意參與可能要約當日屆滿(以較早者為準)之獨家期間。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.